Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
Wei-Wei Zhang,1,2 Feng Bai,1 Jin Wang,1 Rong-Hua Zheng,1 Li-Wang Yang,1 Erskine A James,3 Zhi-Qing Zhao1,4 1Department of Physiology, Shanxi Medical University, 2Department of Anesthesiology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, China; 3Department of Internal Medicine, Navice...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017-10-01
|
| coleção: | Drug Design, Development and Therapy |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/edaravone-inhibits-pressure-overload-induced-cardiac-fibrosis-and-dysf-peer-reviewed-article-DDDT |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
